Abstract
Establishing codon usage biases are crucial for understanding the etiology of central nervous system neurodegenerative diseases (CNSNDD) especially Alzheimers disease (AD) as well as genetic factors. G and C ending codons are strongly biased in the coding sequences of these proteins as a result of genomic GC composition constraints. On the other hand, codons that identified as translationally optimal in the major trend all end in C or G, suggesting translational selection should also be taken into consideration additional to compositional constraints. Furthermore, this investigation reveals that three common codons, CGC (Arg), AGC (Ser), and GGC (Gly), are also critical in affecting codon usage bias. They not only can offer an insight into the codon usage bias of AD and its mechanism, but also may help in the possible cures for these diseases.
Keywords: Codon usage, compositional constraints, translational selection, correspondence analysis
Protein & Peptide Letters
Title: Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Volume: 17 Issue: 5
Author(s): Jie Yang, Tong-Yang Zhu, Zheng-Xin Jiang, Cheng Chen, Yue-Lan Wang, Song Zhang, Xiong-Fei Jiang, Ting-Ting Wang, Lin Wang, Wen-Hao Xia, Lei Li, Ji-Jun Chen, Jia-Yue Wang, Wei-Wei Wang and Wei-Juan Zheng
Affiliation:
Keywords: Codon usage, compositional constraints, translational selection, correspondence analysis
Abstract: Establishing codon usage biases are crucial for understanding the etiology of central nervous system neurodegenerative diseases (CNSNDD) especially Alzheimers disease (AD) as well as genetic factors. G and C ending codons are strongly biased in the coding sequences of these proteins as a result of genomic GC composition constraints. On the other hand, codons that identified as translationally optimal in the major trend all end in C or G, suggesting translational selection should also be taken into consideration additional to compositional constraints. Furthermore, this investigation reveals that three common codons, CGC (Arg), AGC (Ser), and GGC (Gly), are also critical in affecting codon usage bias. They not only can offer an insight into the codon usage bias of AD and its mechanism, but also may help in the possible cures for these diseases.
Export Options
About this article
Cite this article as:
Yang Jie, Zhu Tong-Yang, Jiang Zheng-Xin, Chen Cheng, Wang Yue-Lan, Zhang Song, Jiang Xiong-Fei, Wang Ting-Ting, Wang Lin, Xia Wen-Hao, Li Lei, Chen Ji-Jun, Wang Jia-Yue, Wang Wei-Wei and Zheng Wei-Juan, Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases, Protein & Peptide Letters 2010; 17 (5) . https://dx.doi.org/10.2174/092986610791112666
DOI https://dx.doi.org/10.2174/092986610791112666 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Conotoxin Superfamily Prediction Using Diffusion Maps Dimensionality Reduction and Subspace Classifier
Current Protein & Peptide Science Laterality of Brain Activation for Risk Factors of Addiction
Current Drug Abuse Reviews Editorial (Thematic Issue: Targeting Transporters for CNS Drug Delivery)
Current Pharmaceutical Design Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Current Psychiatry Reviews New Perspectives on the Structure and Function of the Na+ Channel Multigene Family
Current Medicinal Chemistry - Central Nervous System Agents Genetic Variations in CHRNA7 or CHRFAM7 and Susceptibility to Dementia
Current Drug Targets Emerging Signalling and Protein Interactions Mediated Via Metabotropic Glutamate Receptors
Current Drug Targets - CNS & Neurological Disorders Bioactive Constituents from an Endophytic Fungus, Penicillium polonicum NFW9, Associated with Taxus fauna
Medicinal Chemistry Antiviral Medication in Sexually Transmitted Diseases. Part III: Hepatitis B, Hepatitis C
Mini-Reviews in Medicinal Chemistry AMPK As A Target in Rare Diseases
Current Drug Targets Targeting of Peripherally Expressed Pain-Related Molecules in Injury- Induced Chronic Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders
Mini-Reviews in Medicinal Chemistry Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design Knowledge of Pharmacists about Anti-epileptic Drugs in a Developing Country
Current Drug Safety Method to Assess Interactivity of Drugs with Nonparallel Concentration Effect Relationships
Current Cancer Drug Targets Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Pramipexole Tachyphylaxis and its Management in Bipolar Depression
Letters in Drug Design & Discovery Single Amino Acid Repeats Connect Viruses to Neurodegeneration
Current Drug Discovery Technologies Mitochondrial Involvement in Psychiatric Illness in Adults
Current Psychiatry Reviews synthesis and Structure-Activity Relationships of 2,3-Benzodiazepines as AMPA Receptor Antagonists
Mini-Reviews in Medicinal Chemistry